等待开盘
0.000
NaN.00%
Danaher's acquisition of Masimo shows promising financial upside and long-term growth potential with conservative projections.
02-19 02:44
Danaher beat Q4 sales and earnings estimates, showed strength in bioprocessing and diagnostics, and issued a steady 2026 outlook, even as shares traded lower in premarket action.
01-28 22:46